Final Programme - iuphar

FC13 Maximising benefits and minimizing harms from
drugs
Mon 333 Population pharmacokinetics of repaglinide in healthy Malaysian subjects and genetic polymorphisms of
CYP3A4 and CYP2C8
Ruzilawati Abu Bakar, (Malaysia), G Siew Hua, MS Ab Wahab
Mon 334 Bioequivalence study of 1500 mg glucosamine sulfate in Thai healthy volunteers
Pravit Akarasereenont, (Thailand), S Chatsiricharoenkul, P Pongnarin, K Sathirakul, A Wongkajornsilp,
S Kongpatanakul
Mon 335 Protective effect of lafutidine against loxoprofen-induced small intestinal lesions in rats
Kikuko Amagase, (Japan), R Kawahara, S Takayama, T Sugihara, A Ochi, S Kato, K Takeuchi
Mon 336 Cynodon dactylon – a potent, economic, natural anti-diarrhoeal herb in developing countries
Manoj Amrutkar, (India), V Undale, D Bharti, A Bhosale
Mon 337 In vitro characterisation of the clopidogrel bioactivation pathways by cytochromes P450 and potential
drug-drug interactions
Virginie Ancrenaz, (Switzerland), Y Daali, C Samer, M Besson, P Fontana, P Dayer, J Desmeules
Mon 338 Hepatoprotective effect of pistacia lentiscus against isoniazide induced liver toxicity in rats
M Aouichri, M Haouari, L Sfaxi, R Zermani, M Ben-Attia, M Lakhal, Anis Klouz, (Tunisia)
Mon 339 Publication trends of the cytochromes p450 research: 1977–2008
Charles-Daniel Arreto, (France), C Wilson, C Robert
Mon 340 Single-dose pharmacokinetics of cefepime in healthy Egyptian buffalo calves
Taha A Attia, (Egypt), MA Tohamy, AAM El-Gendy
Mon 341 Striatal delivery of CDNF by AAV2 vector is neuroprotective in a rat partial lesion model of Parkinson’s
disease
Susanne Bäck, (Finland), J Peränen, L Lonka, T Tamminen, MH Voutilainen, A Raasmaja, M Saarma,
PT Männistö, RK Tuominen
Mon 342 Cutaneous adverse drug reactions: Analysis of spontaneous reports from healthcare professionals in
Croatia
Ana Balazin, (Croatia), V Macolic-Sarinic, S Arapovic, D Krnic, M Banovac, S Tomic
Mon 343 Serious psychiatric adverse drug reactions spontaneously reported in Croatia from 2006 till 2009
Ana Balazin, (Croatia), V Macolic-Sarinic, S Arapovic, D Krnic, M Banovac, S Tomic
Mon 344 The study of response to bronchodilators according to polymorphism B2-adrenergic receptors
Nadyia Berdnikova, (Russian Federation)
Mon 345 Publication rate among investigator-initiated clinical drug trials in Denmark
Louise Berendt, (Denmark), KF Bach, T Callreus, LG Petersen, HE Poulsen, K Dalhoff
Mon 346 Both heavy and light smoking reduces serum estradiol and estrone in postmenopausal women during
estrogen-progestogen therapy
Nina Hannover Bjarnason, H Jorgensen, C Christiansen
Mon 347 Simvastatin decreases malondialdehyde level in plasma and tissues of rats
Vlasta Bradamante, (Croatia), M Marija, L Jasna, K Marijan, K Pasko
Mon 348 Inhibitory effects of Origanum onites essential oil against contractions of isolated rat vas deferens
induced by Androctonus crassicauda venom
A Cakmak, F Caliskan, Suleyman Aydin, (Turkey)
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 187